Technical Analysis for EVG - Evgen Pharma Plc

Grade Last Price % Change Price Change
grade A 13.1 -1.13% -0.15
EVG closed down 1.13 percent on Friday, May 22, 2020, on 3.41 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical EVG trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -1.13%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.13%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Evgen Pharma plc is a clinical-stage drug development company focused on cancer and neurological disease. The Company operates through the segment of development of pharmaceutical products all within the United Kingdom. Its pipeline is based on its Sulforadex technology and includes various synthetic, stabilized analogues of the naturally occurring compound sulforaphane. Its pipeline includes SFX-01: breast cancer; SFX-01: subarachnoid hemorrhage, and other programs. The objective of SFX-01 therapy is to reduce the number of cancer stem cells (CSCs) proliferating in tumors treated with anti-hormonal agents and prolong the duration of response. The objective of SFX-01 therapy (co-administered with standard-of-care nimodipine) is to reduce the vasospasm and incidence of delayed cerebral ischemia in the days following the hemorrhage. It has a preclinical SFX-01 program in multiple sclerosis and a clinical interest in prostate cancer.
Chemistry Medicine Cancer Rtt Drug Development Pharmaceutical Products Breast Cancer Intensive Care Medicine Multiple Sclerosis Neurosurgery Organic Chemistry Prostate Cancer Stem Cells

Is EVG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 20.5
52 Week Low 2.5
Average Volume 1,256,734
200-Day Moving Average 9.96
50-Day Moving Average 7.57
20-Day Moving Average 11.43
10-Day Moving Average 12.72
Average True Range 1.21
ADX 52.65
+DI 37.70
-DI 9.53
Chandelier Exit (Long, 3 ATRs ) 13.36
Chandelier Exit (Short, 3 ATRs ) 10.84
Upper Bollinger Band 15.14
Lower Bollinger Band 7.72
Percent B (%b) 0.73
BandWidth 64.89
MACD Line 1.65
MACD Signal Line 1.68
MACD Histogram -0.025
Fundamentals Value
Market Cap 9.54 Million
Num Shares 729 Thousand
EPS -62.34
Price-to-Earnings (P/E) Ratio -0.21
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.94
Resistance 3 (R3) 13.90 13.58 13.80
Resistance 2 (R2) 13.58 13.36 13.60 13.76
Resistance 1 (R1) 13.34 13.23 13.18 13.38 13.71
Pivot Point 13.01 13.01 12.93 13.03 13.01
Support 1 (S1) 12.78 12.80 12.61 12.82 12.49
Support 2 (S2) 12.45 12.66 12.47 12.44
Support 3 (S3) 12.21 12.45 12.40
Support 4 (S4) 12.26